Which is better, MOH or WST?

On the Buffett-Fit framework, West Pharmaceutical Services, Inc. (WST) currently grades higher than MOH — 55/100 (C grade) vs 23/100 (F). That said, "better" depends on which framework you trust — MOH wins on Peter Lynch; WST wins on Warren Buffett, Benjamin Graham, Philip Fisher, Joel Greenblatt, Charlie Munger, and Terry Smith. The full pillar breakdown is on this page.

Should I buy MOH or WST?

This page is an educational comparison, not investment advice. Both MOH and WST are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is MOH better than WST for value investing?

On the Buffett-style value-investing framework, WST currently grades higher — 55/100 vs 23/100, a 32-point gap. The gap is driven by which pillars each stock passes; the table on this page shows moat, durability, management, financial health, and valuation side-by-side.

What's the difference between MOH and WST on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). MOH currently scores 23/100 (F grade); WST scores 55/100 (C grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, MOH or WST?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. MOH and WST are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, MOH or WST?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are MOH and WST both Healthcare stocks?

Yes — both Molina Healthcare, Inc. (MOH) and West Pharmaceutical Services, Inc. (WST) operate in the Healthcare sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this MOH vs WST comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

Molina Healthcare

West Pharmaceutical Services

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

MOH

Molina Healthcare

Market cap

$9.64B

Sector

Healthcare

WST

West Pharmaceutical Services

Market cap

$21.21B

Sector

Healthcare

Overall winner

West Pharmaceutical Services WST

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Fit scores by strategy

Strategy	MOH	WST	Winner
Warren Buffett	23F	55C	WST
Benjamin Graham	71B	80A	WST
Philip Fisher

Side-by-side metrics

Metric	MOH	WST
Market cap	$9.64B	$21.21B
P/E (TTM)	50.2x	39.8x
EV/EBIT	10.6x	34.0x
ROIC (TTM)	5.27%	15.24%
Gross margin	9.59%	36.24%
Net margin	0.42%	16.85%
Revenue CAGR 5y	13.09%

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

MOH leads on

Revenue CAGR 5y13.09%vs 2.08%+84%
EV/EBIT10.6xvs 34.0x+69%
EPS CAGR 5y-5.92%vs -6.4%+8%

WST leads on

More like MOH

MOH vs IDXX MOH vs LMAT MOH vs MTD MOH vs HALO MOH vs HRMY MOH vs RPRX

More like WST

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.